| 研究生: |
鄭乃維 Cheng, Nai-Wei |
|---|---|
| 論文名稱: |
探討在葉酸缺乏的斑馬魚胚胎中造成魚鰾缺陷的可能病因 Unraveling the etiology of swim bladder defects observed in folate-deficient zebrafish embryos |
| 指導教授: |
傅子芳
Fu, Tzu-Fun |
| 學位類別: |
碩士 Master |
| 系所名稱: |
醫學院 - 醫學檢驗生物技術學系 Department of Medical Laboratory Science and Biotechnology |
| 論文出版年: | 2014 |
| 畢業學年度: | 102 |
| 語文別: | 英文 |
| 論文頁數: | 54 |
| 中文關鍵詞: | 葉酸 、魚鰾 、半胱胺酸蛋白脢L 、胱蛋白B |
| 外文關鍵詞: | folate, cystatin b, cathepsin L, swimbladder |
| 相關次數: | 點閱:159 下載:2 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
葉酸是水溶性的維他命之一。在人體內中各種生理功能像是核甘酸、胺基酸以及 S-腺苷甲硫氨酸的合成都需要葉酸的存在。而且對於體內去氧核糖核酸、核糖核酸的甲基化扮演著很重要的角色。而葉酸缺乏則是會導致像是神經管缺陷等新生兒先天性的疾病,甚至在成人中,葉酸缺乏也會使得得到心血管疾病以及癌症的風險上升。在之前的研究報導指出在飲食中所含的葉酸會幫助預防肺的癌病變的產生。但是對於葉酸在肺的生理功能以及病理學上的角色則是尚待釐清。在我們的研究中,我們在先前實驗室所建利的斑馬魚葉酸缺乏的動物模式裡,我們發現葉酸缺乏會導致魚鰾的發育有所受損,而魚鰾更是在之前被報導在演化上哺乳類動物的肺的同源器官,我們發現有直到受精後第五天有將近九成的魚鰾沒有辦法正常發育,而這樣的現象是可以利用補充葉酸來回復的。而核糖核酸全胚胎原位雜交的結果中我們發現魚鰾中在受精後第三天時各個組織層的早期發育是沒有受到影響的,而這樣的結果也指出葉酸缺乏是影響了在之後的發育階段。此外我們發現了葉酸缺乏會導致胚胎半胱胺酸蛋白脢L的上升以及胱蛋白B 的下降,所以我們懷疑是不是因為如此而造成魚鰾的细胞外基质的受損而造成魚鰾無法正常的充氣膨脹。另外我們也對這兩種蛋白質的特性作探討分析,斑馬魚胱蛋白B 以及半胱胺酸蛋白脢L 都表現出與哺乳類相像的特性。而我們也純化出胱蛋白B,並且可以成功抑制木瓜蛋白酶的活性,而半胱胺酸蛋白脢L 的純化也正在進行當中。此外我們也看到半胱胺酸蛋白脢L 在胚胎早期會表現在斑馬魚的孵化線以及魚鰾上而胱蛋白B 則是在早期會均勻的表現在細胞中,而晚期則是會表現在斑馬魚心臟、血管以及魚鰾。在最後我們嘗試利用微注射的技術將純化好的胱蛋白B 打進三天大小魚中的魚鰾來進行治療,而結果顯示這樣子是可以成功的降低魚鰾受損的情形,也同時證明了在葉酸缺乏的斑馬魚中所看到的魚鰾受損是由於半胱胺酸蛋白脢L的上升以及胱蛋白B 的下降所導致。
Folate, a water-soluble vitamin, is essential for the biosynthesis of nucleotides, amino acid and S-adenosylmethionine, the major methyl-donor for most methylation reactions in cells. Folate deficiency (FD) causes embryonic defects and diseases including neural tube defect, megaloblastic anemia, cardiovascular disorders and cancers. Dietary folate was reported to protect individuals
against lung carcinogenesis. However, study on both physiological and pathological effects of folate
in lung is still limited. In the current study, we investigate the effects of folate deficiency on the
development of swimbladder, the evolutionary homolog of mammalian lung in zebrafish, using a transgenic line displaying inducible folate deficiency. We found that the swimbladder was absent in approximately 50% of FD embryos at 5 day-post-fertilization (dpf), which was partially reversed by folate supplementation. The results of Whole-mount in situ hybridization (WISH) with probes specific to developing swimbladder indicated a successful formation of swimbladder in FD embryos at early stages, suggesting a post-formation defect. The microarray data obtained from 5-dpf FD
embryos revealed an increased expression of cathepsin L, a lysosomal enzyme with strong elastinolytic activity, and a down-regulation of cystatin b, the inhibitor of cathepsin L in vivo. The up-regulation of cathepsin L was also reversed by folate supplement, supporting the causal link among folate deficiency, up-regulated cathepsin L and disappeared swimbladder. The distribution of cathepsin L mRNA examined by WISH was focused in embryonic hatch gland and swimbladder; whereas the cystatin b transcript was evenly distributed in zebrafish embryos before 24 hour-postfertilization and became focused in the heart and swimbladder of embryos after 1 dpf. The recombinant cystatin b was purified and shown to be structurally and functionally similar to its mammalian orthologs. The recombinant cathepsin L was successfully induced and undergoing
purification. Finally, we used microinject technique to send the recombinant CytB into the 3 dpf swimbladder chamber. And successfully partially rescue the swimbladder defect. In conclusion, our results suggested that the up-regulated cathepsin L and down-regulated cystatin b contributed to the
post-formation defects of zebrafish swimbladder observed in the FD embryos.
X. References
Abboud, R. T. and S. Vimalanathan (2008). "Pathogenesis of COPD. Part I. The role of proteaseantiprotease
imbalance in emphysema." Int J Tuberc Lung Dis 12(4): 361-367.
Anastasi, A., et al. (1983). "Cystatin, a protein inhibitor of cysteine proteinases. Improved purification
from egg white, characterization, and detection in chicken serum." Biochem J 211(1): 129-138.
Aoshiba, K., et al. (2003). "Alveolar wall apoptosis causes lung destruction and emphysematous
changes." American journal of respiratory cell and molecular biology 28(5): 555-562.
Boucherat, O., et al. (2007). "Differential expression of matrix metalloproteinases and inhibitors in
developing rat lung mesenchymal and epithelial cells." Pediatric research 62(1): 20-25.
Butinar, M., et al. (2013). "Stefin B deficiency reduces tumor growth via sensitization of tumor cells
to oxidative stress in a breast cancer model." Oncogene.19 August 2013; doi:10.1038/onc.2013.314.
Chauhan, S. S., et al. (1991). "Expression of cathepsin L in human tumors." Cancer research 51(5):
1478-1481.
Cimerman, N., et al. (2001). "Serum concentration and circadian profiles of cathepsins B, H and L,
and their inhibitors, stefins A and B, in asthma." Clinica Chimica Acta 310(2): 113-122.
Cipollini, E., et al. (2008). "Cystatin B and its EPM1 mutants are polymeric and aggregate prone in
vivo." Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1783(2): 312-322.
Crider, K. S., et al. (2012). "Folate and DNA methylation: a review of molecular mechanisms and the
evidence for folate's role." Adv Nutr 3(1): 21-38.
Croke, M., et al. (2013). "Differences in 53BP1 and BRCA1 regulation between cycling and noncycling
cells." Cell Cycle 12(23): 3629-3639.
Das, B. C., et al. (2013). "Use of zebrafish in chemical biology and drug discovery." Future Med
Chem 5(17): 2103-2116.
46
Droga-Mazovec, G., et al. (2008). "Cysteine cathepsins trigger caspase-dependent cell death through
cleavage of bid and antiapoptotic Bcl-2 homologues." J Biol Chem 283(27): 19140-19150.
Dumbarton, T. C., et al. (2010). "Adrenergic control of swimbladder deflation in the zebrafish (Danio
rerio)." J Exp Biol 213(Pt 14): 2536-2546.
Hsieh, C. S., et al. (2002). "A role for cathepsin L and cathepsin S in peptide generation for MHC
class II presentation." Journal of Immunology 168(6): 2618-2625.
Ishii, T., et al. (2014). "Alveolar macrophage proteinase/antiproteinase expression in lung function
and emphysema." European Respiratory Journal 43(1): 82-91.
Johnson, D. A., et al. (1986). "Cathepsin L inactivates alpha 1-proteinase inhibitor by cleavage in the
reactive site region." Journal of Biological Chemistry 261(31): 14748-14751.
Kao, T. T., et al. (2009). "Recombinant zebrafish {gamma}-glutamyl hydrolase exhibits properties
and catalytic activities comparable with those of mammalian enzyme." Drug Metab Dispos 37(2):
302-309.
Kao, T. T., et al. (2008). "Characterization and comparative studies of zebrafish and human
recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols." Drug Metab Dispos
36(3): 508-516.
Kellermann, J., et al. (1987). "Arrangement of the disulphide bridges in human low-M(r) kininogen."
Biochemical Journal 247(1): 15-21.
Kopitar-Jerala, N. (2006). "The role of cystatins in cells of the immune system." FEBS Letters
580(27): 6295-6301.
Lehtinen, M. K., et al. (2009). "Cystatin B deficiency sensitizes neurons to oxidative stress in
progressive myoclonus epilepsy, EPM1." J Neurosci 29(18): 5910-5915.
Li, F., et al. (2010). "Identification and characterization of a Cystatin gene from Chinese mitten crab
Eriocheir sinensis." Fish and Shellfish Immunology 29(3): 521-529.
47
Lutgens, S. P. M., et al. (2007). "Cathepsin cysteine proteases in cardiovascular disease." The FASEB
Journal 21(12): 3029-3041.
Manninen, O., et al. (2013). "White Matter Degeneration with Unverricht-Lundborg Progressive
Myoclonus Epilepsy: A Translational Diffusion-Tensor Imaging Study in Patients and Cystatin B–
Deficient Mice." Radiology 269(1): 232-239.
McGowan, S. E. (1992). "Extracellular matrix and the regulation of lung development and repair."
FASEB J 6(11): 2895-2904.
Menard, R., et al. (1998). "Autocatalytic processing of recombinant human procathepsin L.
Contribution of both intermolecular and unimolecular events in the processing of procathepsin L in
vitro." J Biol Chem 273(8): 4478-4484.
Novodvorsky, P., et al. (2013). "Zebrafish-based small molecule screens for novel cardiovascular
drugs." Drug Discovery Today: Technologies 10(1): e109-e114.
Onishi, K., et al. (2004). "Cathepsin L is crucial for a Th1-type immune response during Leishmania
major infection." Microbes and Infection 6(5): 468-474.
Pemberton, P. A. (2006). PROTEINASE INHIBITORS | Cystatins. Encyclopedia of Respiratory
Medicine. G. J. Laurent and S. D. Shapiro. Oxford, Academic Press: 511-517.
Premachandra, H. K., et al. (2012). "Cystatin B homolog from rock bream Oplegnathus fasciatus:
genomic characterization, transcriptional profiling and protease-inhibitory activity of recombinant
protein." Comp Biochem Physiol B Biochem Mol Biol 163(1): 138-146.
Premachandra, H. K. A., et al. (2012). "Genomic characterization and expression profiles upon
bacterial infection of a novel cystatin B homologue from disk abalone (Haliotis discus discus)."
Developmental & Comparative Immunology 38(4): 495-504.
Rajan, B., et al. (2011). "Proteome reference map of the skin mucus of Atlantic cod (Gadus morhua)
revealing immune competent molecules." Fish and Shellfish Immunology 31(2): 224-231.
48
Rawlings, N. D., et al. (2004). "Evolutionary families of peptidase inhibitors." Biochemical Journal
378(3): 705-716.
Rzychon, M., et al. (2004). "Modes of inhibition of cysteine proteases Circled white star." Acta
Biochimica Polonica 51(4): 861-873.
Singh, N., et al. (2013). "Prognostic significance of extracellular matrix degrading enzymes-cathepsin
L and matrix metalloproteases-2 [MMP-2] in human pancreatic cancer." Cancer Invest 31(7): 461-
471.
Stover, P. J. (2004). "Physiology of folate and vitamin B12 in health and disease." Nutr Rev 62(6 Pt
2): S3-12; discussion S13.
Strausberg, R. L., et al. (2002). "Generation and initial analysis of more than 15,000 full-length human
and mouse cDNA sequences." Proceedings of the National Academy of Sciences of the United States
of America 99(26): 16899-16903.
Takahashi, H., et al. (1993). "Cathepsin L activity is increased in alveolar macrophages and
bronchoalveolar lavage fluid of smokers." Am Rev Respir Dis 147(6 Pt 1): 1562-1568.
Thisse, C. and L. I. Zon (2002). "Organogenesis - Heart and blood formation from the zebrafish point
of view." Science 295(5554): 457-462.
Thisse, C. and L. I. Zon (2002). "Organogenesis--Heart and Blood Formation from the Zebrafish
Point of View." Science 295(5554): 457-462.
Tingaud-Sequeira, A. and J. Cerda (2007). "Phylogenetic relationships and gene expression pattern
of three different cathepsin L (Ctsl) isoforms in zebrafish: Ctsla is the putative yolk processing
enzyme." Gene 386(1-2): 98-106.
Turk, V. and W. Bode (1991). "The cystatins: Protein inhibitors of cysteine proteinases." FEBS Letters
285(2): 213-219.
Tyagi, C., et al. (2013). "Mechanistic insights into mode of action of novel natural cathepsin L
inhibitors." BMC Genomics 14 Suppl 8: S10.
49
Vogel, A. M. and T. Gerster (1997). "Expression of a zebrafish Cathepsin L gene in anterior
mesendoderm and hatching gland." Development Genes and Evolution 206(7): 477-479.
Winata, C. L., et al. (2009). "Development of zebrafish swimbladder: The requirement of Hedgehog
signaling in specification and organization of the three tissue layers." Dev Biol 331(2): 222-236.
Xiao, P. P., et al. (2010). "Scophthalmus maximus cystatin B enhances head kidney macrophagemediated
bacterial killing." Developmental and Comparative Immunology 34(12): 1237-1241.
Zhang, W., et al. (2014). "Overexpression of cysteine cathepsin L is a marker of invasion and
metastasis in ovarian cancer." Oncol Rep 31(3): 1334-1342.
Zheng, W., et al. (2011). "Comparative transcriptome analyses indicate molecular homology of
zebrafish swimbladder and mammalian lung." PLoS One 6(8): e24019.